Skip to main content
Clinical Trials/ACTRN12612000344897
ACTRN12612000344897
Not yet recruiting
Phase 3

The effect of intravitreal triamcinolone on best corrected visual acuity (BCVA) and visual field in patients with non-arteritic anterior ischemic optic neuropathy.

Khon Kaen University0 sites20 target enrollmentMarch 26, 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
on-arteritic Anterior Ischemic Optic Neuropathy
Sponsor
Khon Kaen University
Enrollment
20
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 26, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • acute painless visual loss
  • \- localized optic disc edema
  • \- no associated symptoms (; i.e. headache/scalp tenderness/jaw claudication)
  • \- unilateral involvement with the normal fellow eye
  • \- no previous attack or treatment

Exclusion Criteria

  • \- ocular and/or orbital infection
  • \- other ocular disease that might interfere with visual acuity and/ or the visual field

Outcomes

Primary Outcomes

Not specified

Similar Trials